XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.66

+2.8%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (10889)	7/23/1999 12:36:00 AM
From: LarryS	Read Replies (1) of 17367

Maybe a good buy would be to wait until we get a better understanding (after unblinding) of how effective Neuprex is. If it's as good as we hope buy AGN then, because virtually none of their investors/analysts will know anything about BPI/Iprex/Xoma. When the word gets around, and their investors see value in Iprex, the stock might make a move up. Speaking of analysts, maybe some that follow AGN will do some research on Iprex and be intrigued by Xoma...and issue buys. Hope tomorrow will move us back above 7. Earnings and unblinding in less than a month...sure is starting to get interesting after all these months.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next